- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Cryosurgery.
Displaying page 1 of 1.
EudraCT Number: 2014-005121-13 | Sponsor Protocol Number: Daylight_01 | Start Date*: 2015-07-22 |
Sponsor Name:University Hospital Regensburg | ||
Full Title: Prospective, randomized, controlled, multicenter, two-armed, study comparing daylight photodynamic therapy using MAL with cryosurgery for the treatment and prophylaxis of actinic keratoses in photo... | ||
Medical condition: Actinic keratoses and photoaged skin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003556-36 | Sponsor Protocol Number: AK 04 | Start Date*: 2006-03-10 |
Sponsor Name:photonamic GmbH & Co. KG | ||
Full Title: Photodynamic Therapy with PD P 506 A or its placebo compared with cryosurgery for the treatment of mild to moderate actinic keratosis | ||
Medical condition: Actinic Keratosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003339-21 | Sponsor Protocol Number: VEPLAN-2014-01 | Start Date*: 2015-06-02 |
Sponsor Name:Institut d'Investigació Sanitària Pere Virgili (IISPV) | ||
Full Title: Open, randomized, with two parallel treatment groups combined therapy with bleomycin and with bleomycin electrochemotherapy (EQ) in patients with plantar warts large clinical trial virus. Diagnosis... | ||
Medical condition: viral wart | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002785-39 | Sponsor Protocol Number: BRN-C-2013-04 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Laboratoires BOIRON | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005820-24 | Sponsor Protocol Number: IIS-PICATO1264 | Start Date*: 2016-09-09 | |||||||||||
Sponsor Name:A.O.U. Università degli Studi della Campania "Luigi Vanvitelli" | |||||||||||||
Full Title: A randomized study to evaluate the efficacy of ingenol mebutate on actinic keratoses and field cancerization compared to cryotherapy | |||||||||||||
Medical condition: actinic keratoses and field cancerization | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003977-24 | Sponsor Protocol Number: SGI-110-03 | Start Date*: 2014-03-20 | |||||||||||
Sponsor Name:Astex Pharmaceuticals Inc | |||||||||||||
Full Title: A Phase 2 Study of SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Subjects Who Failed Prior Treatment with Sorafenib | |||||||||||||
Medical condition: Advanced Hepatocellular Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004524-11 | Sponsor Protocol Number: 2013105 | Start Date*: 2013-12-16 | ||||||||||||||||
Sponsor Name:Proctor and Gamble Technical Centres Ltd | ||||||||||||||||||
Full Title: A 2-arm, randomised, single - (investigator) blind, controlled, parallel design study in common cold sufferers experiencing cough and nasal congestion to assess the effects of Vicks® VapoRub® (VVR)... | ||||||||||||||||||
Medical condition: Sleep disruption due to cough and nasal congestion during a cold. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-003559-32 | Sponsor Protocol Number: CPO19001 | Start Date*: 2023-03-16 | ||||||||||||||||
Sponsor Name:PharOS Pharmaceutical Oriented Services Single Member Ltd. | ||||||||||||||||||
Full Title: A Phase III Prospective, Randomized, Multicenter, Double-Blind, Placebo-controlled clinical study to evaluate the efficacy and safety of fixed dose combination (FDC) product Ibuprofen/Paracetamol/P... | ||||||||||||||||||
Medical condition: Temporary relief of cold and flu symptoms, i.e. mild to moderate pain, sore throat, fever and nasal congestion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
